Hellen Kim Email & Phone Number

Boston, Ma, Us

Key Highlights:- Launched 3 companies in the last 5 years, expanding CPD’s oncology and inflammation portfolio- Streamlined program execution through optimized decision-making processes, saving time and reducing delays- Drove alignment across internal and external stakeholders, ensuring programs met critical development milestones- Championed strategic business and financial planning, enhancing the overall success rate of portfolio programs- Optimized IND development timelines, maintaining key milestones on track and mitigating project risks proactively- Accelerated GMP scale-up and clinical development, resulting in on-time drug product development for FIH Ph1

Boston, Massachusetts, Us

Key Achievements:- Successfully managed multiple cross-functional programs, ensuring timely delivery of milestones, including the transition of multiple pre-clinical programs to clinical development- Advanced DMD research through strategic alliances with collaborators, facilitating significant progress in early-stage and clinical development- Streamlined communication and operational efficiency across internal and external teams, enhancing accountability and program success- Led efforts to implement new scientific technologies, improving assay capabilities for PK/PD correlation and advancing drug development

Key Achievements:- Led three small molecule discovery programs from early pre-clinical stages, providing strategic oversight and risk mitigation to ensure timely advancement toward IND submission- Fostered cross-functional collaboration with chemists, bioinformaticians, and CROs, driving alignment and progress on key program milestones- Supported budget and resource tracking, ensuring efficient allocation of funds and adherence to program timelines- Contributed scientific expertise to biomarker development for Phase 1 clinical trials, enhancing the cystic fibrosis program's data capabilities- Mentored junior scientists, cultivating a productive and positive team environment

New York, New York, Us

Key Achievements:- Led the strategic planning and execution of key pre-clinical activities for the cystic fibrosis gene therapy program, advancing it toward IND submission- Enhanced collaboration with academic partners and internal stakeholders by ensuring clear and consistent communication and follow-up on action items- Pioneered biomarker discovery and early efficacy assessments, providing critical data for the progression of the cystic fibrosis program- Spearheaded assay development for early discovery research, enabling efficient high-throughput screening and target validation- Drove strategic licensing and partnership decisions, contributing to the growth of Pfizer’s rare disease pipeline

Cambridge, Ma, Us

Rahway, New Jersey, Us

Philadelphia, Pa, Us